Here are three stocks with buy rank and strong income characteristics for investors to consider today, January 12th:Exxon Mobil XOM: This company that explores for and produces crude oil and natural gas has witnessed the Zacks Consensus Estimate for its current year earnings increasing 2% over the last 60 days.Exxon Mobil Corporation Price and Consensus Exxon Mobil Corporation price-consensus-chart | Exxon Mobil Corporation QuoteThis Zacks Rank #1 (Strong Buy) company has a dividend yield of 5.14%, compared with the industry average of 4.06%.Exxon Mobil Corporation Dividend Yield (TTM) Exxon Mobil Corporation dividend-yield-ttm | Exxon Mobil Corporation QuoteAnalog Devices ADI: This original equipment manufacturer of semiconductor devices has witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.3% over the last 60 days.Analog Devices, Inc. Price and Consensus Analog Devices, Inc. price-consensus-chart | Analog Devices, Inc. QuoteThis Zacks Rank #1 company has a dividend yield of 1.62%, compared with the industry average of 0.00%.Analog Devices, Inc. Dividend Yield (TTM) Analog Devices, Inc. dividend-yield-ttm | Analog Devices, Inc. QuoteAllianceBernstein AB: This publicly owned investment manager has witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.4% over the last 60 days.AllianceBernstein Holding L.P. Price and Consensus AllianceBernstein Holding L.P. price-consensus-chart | AllianceBernstein Holding L.P. QuoteThis Zacks Rank #1 company has a dividend yield of 7.13%, compared with the industry average of 1.98%.AllianceBernstein Holding L.P. Dividend Yield (TTM) AllianceBernstein Holding L.P. dividend-yield-ttm | AllianceBernstein Holding L.P. QuoteSee the full list of top ranked stocks here.Find more top income stocks with some of our great premium screens Breakout Biotech Stocks with Triple-Digit Profit Potential The biotech sector is projected to surge beyond $2.4 trillion by 2028 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases. Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Recommendations from previous editions of this report have produced gains of +205%, +258% and +477%. The stocks in this report could perform even better.See these 7 breakthrough stocks now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Analog Devices, Inc. (ADI): Free Stock Analysis Report Exxon Mobil Corporation (XOM): Free Stock Analysis Report AllianceBernstein Holding L.P. (AB): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research